Physician profile
Eric Wilkinson
NPI 1407119399
$12,790.75
in general payments reported to CMS, 2019-2025
7 companies · $2,095 in 2025
The $2,095 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.57 · 2021: $389 · 2022: $5,647 · 2023: $3,199 · 2024: $1,435 · 2025: $2,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,168 · Food and Beverage: $1,895 · Education: $1,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,167.61 |
| Food and Beverage | $1,894.74 |
| Education | $1,666.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $4,797.85 | 2022-2025 | |
| Smith+Nephew, INC. | $4,069.43 | 2020-2023 | Accu-Pass, Footprint, Healicoil |
| Stryker Corporation | $1,815.17 | 2023-2025 | Blueprint Patient Specific Instrumentation, Pangea, T2 Alpha |
| Arthrex, INC. | $1,657.61 | 2023-2025 | |
| Miach Orthopaedics, INC. | $320.78 | 2025 | |
| Osteomed LLC | $88.41 | 2022 | |
| Vericel Corporation | $41.50 | 2023-2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wilkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.